Cellcept 500 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,677
Award facts
- Contract value 100% obligated
- $12,677.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) under a firm fixed-price contract valued at $12,677.02. The delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location in the same city. CellCept is an immunosuppressant medication commonly used in military and veteran healthcare systems to prevent organ rejection and treat certain autoimmune conditions.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen provides critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive pharmaceutical supply portfolio across multiple therapeutic domains, positions it as a key vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9GZ9?
SPE2DR26F9GZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9GZ9 worth?
The government has obligated $12,677 on SPE2DR26F9GZ9.
Is contract SPE2DR26F9GZ9 an order under another contract?
Yes. SPE2DR26F9GZ9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GZ9 competed?
The extent of competition for SPE2DR26F9GZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award